Navigation Links
Cell Therapeutics Announces Planned Reverse Stock Split; Receives NASDAQ Notice of Non-Compliance; Intends to Request Hearing
Date:5/6/2011

the Common Stock for as long as 20 business days.

It is presently anticipated that the reverse stock split will become effective on or about May 15, 2011. Upon the effectiveness of the reverse stock split, each of the Company's shareholders will receive one new share of Common Stock in exchange for every six shares such shareholder holds. The Common Stock will begin trading on a split-adjusted basis on the Mercato Telematico Azionario stock market (the "MTA") in Italy and The NASDAQ Capital Market in the United States on May 16, 2011. On The NASDAQ Capital Market, trading of the Common Stock will appear under the temporary trading symbol "CTICD" in order to inform the investment community of the reverse stock split. The Company's trading symbol will revert to "CTIC" on or about June 13, 2011.  The Company's trading symbol on the MTA will not change due to the reverse stock split.

The reverse stock split will affect all outstanding and authorized shares of the Common Stock as well as the number of shares of Common Stock underlying stock options and other exercisable or convertible instruments outstanding at the effective time of the reverse stock split.

About Cell Therapeutics, Inc.

Headquartered in Seattle, the Company is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit www.celltherapeutics.com.

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results and the trading price of the Company's securities. Specifically, the risks and uncertainties that could the Company include risks associated with preclinical and clinical developments in the biopharmaceutical industry, including, without limitation, that
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... /PRNewswire-iReach/ -- Today leading web researchers Change Sciences Group ... web sites for usability, engagement, and conversion. The rankings ... which compares how people experience sites with competitors and ... The top three performers are easier to use, more ... performers have usability problems, lack aspects of design that ...
(Date:6/19/2013)... MOUNTAIN VIEW, Calif. , June 19, 2013 ... a leading provider of medication and supply management ... announced that it was named the number one ... Medical Equipment & Infrastructure Report. KLAS, a leading ... all pharmacy automation equipment vendors in its annual ...
(Date:6/19/2013)... 2013  It may seem like an odd pairing: an ... But these were two of the most talked about topics ... Meeting & Expo that just convened in San ... by some of the top internal medicine experts in the ... research that can not only save lives, but help people ...
Breaking Medicine Technology:Sunovion tops new Change Sciences User Experience Rankings for Pharmaceutical Industry while McNeil-PPC ranks worst overall 2Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 2Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 3Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 4"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 3"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 4
(Date:6/19/2013)... 19, 2013 As warmer weather arrives ... Brookstone Lodge on some summertime packages. , “Whether guests ... looking for a fun staycation, we think that these ... and families. Asheville is so beautiful in the summertime ... several options that guests can choose from, based on ...
(Date:6/19/2013)... Scottsdale, AZ (PRWEB) June 19, 2013 Are ... could be losing clients to the competition. , Social ... sales at your massage practice. , Included in your ... into an effective tool in building awareness and revenue for ... now over 5.5 million Twitter users worldwide. Many of these ...
(Date:6/19/2013)... CCA , America's leader in ... to Vice President, Health Services, effective June 8, 2013. ... Services for CCA. He will replace the retiring ... privilege to lead CCA's dedicated team of health care ... society and our partners as we provide effective care ...
(Date:6/19/2013)... Chrysler made news recently when it refused ... million Jeeps. The Jeep models in question are the 1993-2004 ... to the NHTSA are vulnerable to fire and explosion in ... are rear-mounted and have been alleged to catch fire or ... Cherokee with 32 rear-end crashes, which resulted in 44 deaths ...
(Date:6/19/2013)... June 19, 2013 According to a June ... Weekend Sunburn,” it is not uncommon for a person to ... months. A person is likely to forget to reapply sunscreen ... is both dry and itchy. When this occurs, it is ... goo.gl/gDyjP). , “Most people do not realize that milk contains ...
Breaking Medicine News(10 mins):Health News:Fun Depot Partners with Brookstone Lodge on Summer Packages 2Health News:If Your Massage Practice Isn’t Tweeting, It Isn’t Generating New Sales: 3 Ways Twitter Helps Grow Massage Practices from Appointment-Plus 2Health News:CCA Names Dr. John Baxter Vice President, Health Services 2Health News:Zinda & Davis PLLC: Why the Chrysler Recall Refusal Matters And May Set a Dangerous Precedent 2Health News:Zinda & Davis PLLC: Why the Chrysler Recall Refusal Matters And May Set a Dangerous Precedent 3Health News:Skin Care – How to treat Sunburn 2
... release is available in Spanish . U.S. ... laboratory rats fed blueberries or other foods of interest may ... has paved the way to follow-up experiments, Rosalia C. M. ... Rock, Ark., has determined that several indicators of rat mammary ...
... more common disease striking overweight, younger women is the ... where an osteopathic physician is testing the effectiveness of ... Idiopathic intracranial hypertension, known as IIH or pseudo-tumor cerebri, ... the brain, specifically in the absence of a tumor. ...
... year, 10,000 pregnant women and up to 200,000 newborn babies ... globe have for years been looking in vain for a ... have found the biochemically weakness of the lethal malaria parasite, ... related malaria. The malaria parasite travels via the spit ...
... with colon cancer that had spread to distant sites found ... drug regimen that was not recommended. Those patients were exposed ... for the drugsof more than $2 million. The study, ... the American Society for Clinical Oncology,s annual meeting in Chicago, ...
... Blocking two tiny molecules of RNA a chemical ... of blood vessels that occurs in degenerative eye disorders, UT ... in the Proceedings of the National Academy of Sciences ... (AMD), a vascular eye disorder that affects nearly 2 million ...
... (HealthDay News) -- One of the first and largest national ... that those who identify as gay, lesbian or bisexual are ... The study was conducted by the U.S. Centers for ... 2001-2009. It found that rates of smoking, drinking or other ...
Cached Medicine News:Health News:Mammary gland development of blueberry-fed lab animals studied 2Health News:Researcher tests drug's impact on neurological disease affecting women 2Health News:Researchers discover biochemical weakness of malaria parasite -- vaccine to be developed 2Health News:Many patients with advanced cancers get treatments that won't help 2Health News:Many patients with advanced cancers get treatments that won't help 3Health News:Researchers find that inhibiting microRNAs may help prevent degenerative eye disorders 2Health News:More Risky Behaviors Among Gay, Bisexual High School Students: CDC 2
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
... been selling replacement bulbs on ... we are extremely proud of ... out our catalog of replacement ... light bulbs specials. ,Check ...
... With the Symphony family of Pacemakers, ... the market. Symphony, lighter than a passport, ... follow-up, using new technologies, and delivering powerful ... also indicated for dual-chamber and atrial tracking ...
With the Symphony family of Pacemakers, Ela presents the most advanced technology on the market. Symphony, lighter than a passport, will take your patients further, offering fast follow-up, using new...
Medicine Products: